Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

164
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
164
Pneumonia IV: Management01:28

Pneumonia IV: Management

665
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
665
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

199
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
199
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

369
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
369
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

657
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
657
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.0K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitamin C in acute critical illness: don't confuse pharmacotherapy and nutrition!

Intensive care medicine·2026
Same author

Impact of Tibetan Ancestry on Respiratory Control and Central Sleep Apnea in Hypoxia.

Journal of sleep research·2026
Same author

Consensus statement from the 2025 Delphi panel on cerebral microdialysis in critical care.

Critical care (London, England)·2026
Same author

Altitude-induced periodic breathing optimises respiratory efficiency during sleep in young healthy males.

Thorax·2026
Same author

Hypoalbuminemia During the First 24 Hours Is Not an Independent Risk Factor for Mortality in Major Burns.

Journal of burn care & research : official publication of the American Burn Association·2026
Same author

What does "PICS" mean in major burns? Persistent critical illness or post-intensive care syndrome.

Burns : journal of the International Society for Burn Injuries·2026

Related Experiment Video

Updated: Dec 23, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.0K

[COVID-19 : Intensive care management].

Marie Krähenbühl1, Mauro Oddo1, Lise Piquilloud1

  • 1Service de médecine intensive adulte, CHUV, 1011 Lausanne.

Revue Medicale Suisse
|April 30, 2020
PubMed
Summary

Severe acute respiratory distress syndrome (ARDS) in COVID-19 patients presents unique challenges for intensive care medicine. This article summarizes specific characteristics of COVID-19-related ARDS requiring mechanical ventilation.

Area of Science:

  • Critical Care Medicine
  • Pulmonology
  • Infectious Diseases

Background:

  • COVID-19, caused by SARS-CoV-2, presents significant challenges in intensive care.
  • A substantial percentage of COVID-19 patients require intensive care unit (ICU) admission and prolonged stays.
  • Severe acute hypoxemic respiratory failure necessitates invasive mechanical ventilation in up to 5% of cases.

Purpose of the Study:

  • To summarize the specific characteristics of COVID-19-related ARDS.
  • To highlight the unique aspects of managing these patients in intensive care.

Main Methods:

  • Review of recently acquired data and clinical experience.
  • Synthesis of information regarding COVID-19-related ARDS management.

More Related Videos

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

4.3K
Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
10:38

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

Published on: January 16, 2019

20.7K

Related Experiment Videos

Last Updated: Dec 23, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.0K
An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

4.3K
Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
10:38

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

Published on: January 16, 2019

20.7K

Main Results:

  • COVID-19-related ARDS exhibits distinct features compared to other forms of ARDS.
  • Protective mechanical ventilation is a primary supportive treatment for lung injury.

Conclusions:

  • Understanding the specificities of COVID-19 ARDS is crucial for effective intensive care.
  • This article provides a summary of these unique characteristics for clinicians.